Utah Rhinology and Oncology Care (UROC) Innovations Lab
Abby Pulsipher, PhD, is Director of UROC Innovations, a cross-disciplinary laboratory that unites researchers and clinicians with complementary expertise in pharmaceutical and drug delivery sciences, cell and molecular immunology, product development, and clinical and translational medicine. The UROC Innovations Lab is focused on developing and evaluating new disease models, therapeutics and drug delivery systems, and diagnostic solutions for upper airway diseases and head and neck oncology, as well as elucidating the pathophysiologic mechanisms underpinning these conditions.
Deans Lab
The goal of the Deans laboratory is to understand the development of Planar Polarity, a unique aspect of biological structure manifest by the polarized organization of cellular components within the plane of an epithelium.
Park Lab
The Park Lab is a unique, truly translational bench to bedside program dedicated to treat cytomegalovirus (CMV). The clinical branch is focused on the role of valganciclovir for congenitally infected (cCMV) infants with isolated sensorineural hearing loss. We are conducting an NIH funded multi-institutional clinical trial to address this question (ValEAR CMV trial). Our laboratory is particularly interested in understanding the mechanisms underlying CMV induced hearing loss.
Voice, Airway, Swallowing, Translational (VAST) Research Lab
Dr. Julie Barkmeier-Kraemer is Director of the Voice, Airway, Swallowing Translational (VAST) Research Lab. This lab supports funded and unfunded projects addressing normal and abnormal voice, breathing and swallowing.